New guidelines on the management of metastatic, hormone-sensitive prostate cancer have just been released by the American Society for Clinical Oncology (ASCO), based primarily on data from the CHAARTED, STAMPEDE, and LATITUDE trial data. The full text of these new guidelines, developed by Morris et al., is available on line in the Journal of Clinical […]
↧